Additionally, to fully rationalize and optimize the application of CREB inhibitors in cancer therapy, future research should focus on: (1) determining the extent CREB inhibition underlies antitumor effect and (2) identifying effective drug combinations and schedules involving CREB-targeting drugs. Here, CREB1 is linked to cancer.